US Broker Ratings

Canopy Growth Corporation (CGC) Stock Analysis: Exploring a Potential 81% Upside Amidst Valuation Challenges

Canopy Growth Corporation (NASDAQ: CGC), a key player in the cannabis and hemp industry, is drawing attention from investors with its substantial potential upside of 81.06%. Despite a turbulent market..

Varex Imaging Corporation (VREX) Stock Analysis: Exploring the 73% Potential Upside

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector specializing in medical devices, presents a compelling investment case with a notable potential upside of 73.26%. Headquartered in..

National Research Corporation (NRC) Stock Analysis: Evaluating the 3.23% Dividend Yield Amidst Revenue Challenges

National Research Corporation (NASDAQ: NRC), a key player in the health information services industry, offers a unique proposition for investors with its blend of robust dividend yield and innovative solutions..

Aura Biosciences, Inc. (AURA) Stock Analysis: A Transformative Biotechnology Play with 198.51% Potential Upside

Aura Biosciences, Inc. (NASDAQ: AURA) is capturing the attention of investors as a promising player in the biotechnology sector. With a market capitalization of $429.81 million, this Boston-based clinical-stage biotechnology..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a 207% Potential Upside for Investors

Alpha Teknova, Inc. (NASDAQ: TKNO), a prominent player in the healthcare sector specializing in the production of critical reagents, is capturing the attention of savvy investors with its impressive potential..

Senseonics Holdings, Inc. (SENS) Stock Analysis: A Soaring 184% Potential Upside Beckons Investors

Investors on the lookout for high-growth potential opportunities in the healthcare sector may find Senseonics Holdings, Inc. (NASDAQ: SENS) a compelling prospect. This medical device company, with a market capitalization..

Health Catalyst, Inc. (HCAT) Stock Analysis: Exploring a 69% Potential Upside in Healthcare Analytics

Health Catalyst, Inc. (NASDAQ: HCAT), a prominent player in the health information services industry, is making waves among investors with a notable potential upside of 69.34% based on analyst ratings...

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Unveiling a Potential 184% Upside in Biotech Innovation

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector, capturing investor attention with its impressive potential for upside. With a current market capitalization..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Unveiling a 279% Potential Upside in the Biotech Space

Candel Therapeutics, Inc. (NASDAQ: CADL) is capturing the attention of the biotech investment community with a compelling investment narrative centered on its promising cancer immunotherapy pipeline. With a current market..

Zhengye Biotechnology Holding L (ZYBT): Navigating Challenges with a Focus on Veterinary Vaccines in China

Investors in the healthcare sector might find Zhengye Biotechnology Holding L (ZYBT) an intriguing yet challenging prospect due to its niche focus on veterinary vaccines. Based in Jilin, China, the..

Outset Medical, Inc. (OM) Stock Analysis: Exploring a 173% Potential Upside with Innovative Hemodialysis Solutions

Outset Medical, Inc. (OM), a promising player in the medical devices sector, might just be the opportunity investors are looking for, given its substantial potential upside of 173.44%. Specializing in..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Unpacking the 173.52% Potential Upside Amidst Robust Revenue Growth

ClearPoint Neuro Inc. (NASDAQ: CLPT), a pioneering entity in the healthcare sector, is making waves in the medical devices industry with its innovative platform for minimally invasive brain surgeries. With..

Rigel Pharmaceuticals, Inc. (RIGL): Investor Outlook with 86% Potential Upside

For investors seeking opportunities in the biotechnology sector, Rigel Pharmaceuticals, Inc. (RIGL) offers a compelling prospect with its impressive potential upside of 86.18%. The company, headquartered in South San Francisco,..

TotalEnergies SE (TTE) Stock Analysis: Balancing a Robust Dividend Yield with Modest Growth Potential

TotalEnergies SE (NYSE: TTE), a major player in the integrated oil and gas sector, offers a compelling proposition for investors seeking exposure to the energy market with a robust dividend..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Potential 207% Upside Sparks Investor Interest

For investors keeping a keen eye on the healthcare sector, particularly the medical devices industry, Nano-X Imaging Ltd. (NASDAQ: NNOX) stands out as a compelling opportunity. Based in Israel, this..

Erasca, Inc. (ERAS) Stock Analysis: A Promising Biotech with Analyst Consensus and Growth Potential

Erasca, Inc. (ERAS), a clinical-stage biotechnology company, is gaining traction in the healthcare sector with its focus on precision oncology. Specializing in the development of therapies targeting RAS/MAPK pathway-driven cancers,..

Mereo BioPharma Group (MREO) Stock Analysis: Unpacking a 423% Potential Upside

For investors with a keen interest in the biotechnology sector, Mereo BioPharma Group plc (NASDAQ: MREO) presents a fascinating opportunity. This London-based biopharmaceutical company, with a market capitalization of $52.67..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 52.83% Potential Upside in Bioelectric Medicine

Investors seeking opportunities in the burgeoning healthcare sector might find Pulse Biosciences, Inc. (NASDAQ: PLSE) a compelling consideration. With its innovative approaches in bioelectric medicine and a significant potential upside,..

MannKind Corporation (MNKD) Stock Analysis: Exploring a Potential 216% Upside in the Biotech Space

MannKind Corporation (MNKD), a pivotal player in the biotechnology sector, presents an intriguing investment opportunity with a potential upside of 216.46%, according to analyst ratings. Specializing in groundbreaking solutions for..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 70% Potential Upside in a Challenging Market

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the medical devices sector, presents a compelling case for investors willing to navigate its current challenges in pursuit of significant..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds